May 12, 2024. T-CURX to participate at BioEquity Europe conference

T-CURX management will attend the 2024 BioEquity conference taking place from Ma y 12-14 in San Sebastian, Spain

T-CURX, a leading European Biotech company in the field of developing next-generation CAR-T cell therapies for cancer patients, will participate at the 24th Bio€quity congress, taking place from May 12-14, 2024 at the Kursaal Elkargunea Center in San Sebastián, Spain. T-CURX CEO, Ulf Grawunder, will be available for partnering discussions and 1:1 meetings with parties interested in making CAR-T therapies more accessible to patients leveraging T-CURX non-viral transposon LNP technology for bedside CAR-T manufacturing.

For more information on this congress, please visit the conference's web-site at: https://conferences.biocentury.com/bioequity-europe